指南与共识脑血管病

血栓性血小板减少性紫癜:卒中预防指南中被忽视的病因

Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines.
指南 / 共识 · Stroke · 2025-03-07

2024年美国心脏协会和美国卒中协会更新了卒中一级预防指南,强调可调控危险因素,但未纳入血栓性血小板减少性紫癜。作者指出此类患者易发生卒中且卒中可为唯一表现,建议未来指南增加相关推荐,并在隐源性卒中检查中考虑检测ADAMTS13活性。

要点

  • 2024版卒中一级预防指南未纳入血栓性血小板减少性紫癜。
  • 血栓性血小板减少性紫癜患者易发生卒中,卒中可为唯一表现。
  • 作者建议隐源性卒中检查中考虑检测ADAMTS13活性。

核心结论

  • 2024年卒中一级预防指南未包含血栓性血小板减少性紫癜的特异性推荐,未来指南应纳入以预防包括卒中在内的血栓事件。

研究设计与样本

  • 本文为针对2024年美国心脏协会和美国卒中协会卒中一级预防指南的评述文章。

主要发现

  • 指南涵盖高血压、糖尿病、动脉粥样硬化性疾病及卒中遗传易感性等,但未对血栓性血小板减少性紫癜给出推荐。
  • 血栓性血小板减少性紫癜与缺血性卒中相关,且卒中可为该病的唯一表现。

关键数值与推荐

  • 作者提出在隐源性卒中的检查中应考虑检测ADAMTS13活性。

临床怎么用

  • 作者认为未来指南应包含血栓性血小板减少性紫癜患者的特异性推荐以预防卒中。
  • 作者建议在隐源性卒中的检查中考虑检测ADAMTS13活性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 2024 Guidelines for the Primary Prevention of Stroke, recently updated by the American Heart Association and the American Stroke Association, serve as an essential resource for clinicians aiming to reduce the growing impact of cerebrovascular disease. These guidelines emphasize modifiable risk factors and population-specific considerations, covering a range of cardiovascular conditions, including hypertension, diabetes, atherosclerotic disease, and genetic predispositions to stroke. However, a notable omission in these guidelines is the absence of specific recommendations for patients with thrombotic thrombocytopenic purpura. Indeed, these patients are particularly susceptible to stroke, which can be the sole manifestation of the disease. Given the established association between thrombotic thrombocytopenic purpura and ischemic stroke and the effectiveness of preventive interventions, future guidelines should include specific recommendations for patients with thrombotic thrombocytopenic purpura to avert thrombotic events, including stroke. In that regard, ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) activity measurement should be considered in the workup of cryptogenic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Picod A, Joly BS, Veyradier A, et al. Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines. Stroke. 2025. PMID: 40052283. doi:10.1161/STROKEAHA.124.049952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。